Torrent Pharmaceuticals Ltd

BSE Code : 500420
NSE Symbol : TORNTPHARM
ISIN : INE685A01028
Industry :PHARMACEUTICALS - INDIAN - FORMULATIONS

Trade Now

Get Quotes

3,164.00 -63.00(-1.95%)

Open Price (₹)

3,245.00

Prev. Close (₹)

3,227.00

Volume (No’s)

230,664

Market Cap (₹)

109,211.44

Low Price (₹)

3,150.00

High Price (₹)

3,245.00

Chart

Technical Chart

Corparate Information

Financials

Corporate Action

Board Meetings

Start Date	End Date	Purpose
13-May-2025	20-May-2025	Torrent Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2025 inter alia to consider and approve the Audited Financial Results of the Company for the year ended on 31-Mar-25; Recommendation of final dividend; Taking enabling resolutions for raising of funds by issue of Equity Shares including Convertible Bonds / Debentures through QIP and / or Depository Receipts or any other modes. Outcome of Board meeting dated 20-May-25 (As Per BSE Announcement Dated on :20.05.2025)
13-Jan-2025	24-Jan-2025	TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2025 inter alia to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and nine months ended on 31-Dec-24. The Board would also consider payment of Interim Dividend for the year 2024-25. Outcome of Board Meeting Dated 24-Jan-25. Dividend Updates (As per BSE Announcement Dated on 24/01/2025)
10-Oct-2024	25-Oct-2024	TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/10/2024 inter alia to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and half year ended on 30-Sep-24. Results Q2 FY 2024-25. (As Per BSE Announcement dated on 25.10.2024)
05-Jul-2024	23-Jul-2024	TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2024 inter alia to consider and approve We would like to inform you that a meeting of the Board of Directors will be held on Tuesday 23-Jul-24 inter alia to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter ended on 30-Jun-24. Outcome of Board Meeting Dated 23-07-2024. (As Per BSE Announcement dated on 23.07.2024)
10-May-2024	24-May-2024	TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2024 inter alia to consider and approve We would like to inform you that: 1. A meeting of the Board of Directors will be held on Friday 24-May-24 inter alia to consider and approve the Audited Financial Results of the Company for the year ended on 31-Mar-24. 2. In the above meeting the Board would also consider the following: i. Recommendation of final dividend if any on the equity shares of the Company for the year 2023-24. ii. Taking enabling resolutions for raising of funds by issue of Equity Shares including Convertible Bonds / Debentures through Qualified Institutional Placement (QIP) and / or Depository Receipts or any other modes. If approved by the Board of Directors the said item will be placed for Shareholders approval in the ensuing Annual General Meeting. Kindly take note of the above. Outcome of Board meeting dated 24-May-24 Results (As Per BSE Announcement dated on 24.05.2024)